Aldeyra Therapeutics ALDX
NASDAQ ALDX
$0.71 -0.02 (-2.79%)
As of: Oct 21, 2026 · 10:51 AM EDT

Aldeyra Therapeutics (ALDX) Other financing activities (2017 - 2024)

Updated

Aldeyra Therapeutics' Other financing activities was $292,500 in Q4 2024, down 42.6% from $509,549 a year earlier.

Analysis

Aldeyra Therapeutics (ALDX) Other financing activities (2017 - 2024) Analysis & Trends

From Q1 2019 onward, Aldeyra Therapeutics has reported Other financing activities for 6 quarters.

  • Other financing activities shows a five-year compound annual growth rate of 18.9% (FY2019 to FY2024).
  • In earlier years, Other financing activities was $1.04 million in FY2023.
  • The Q4 2024 figure marks the lowest quarterly Other financing activities since Q3 2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,132.04 Bn 1,100.62 Bn 19.71 Bn
2 Johnson & Johnson 614.86 Bn 533.39 Bn 17.26 Bn
3 AbbVie 503.32 Bn 476.44 Bn 12.70 Bn
4 Merck 367.14 Bn 321.52 Bn 12.21 Bn
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn
6 Astrazeneca 261.69 Bn 235.37 Bn 12.86 Bn
7 Amgen 236.43 Bn 191.82 Bn 7.24 Bn
8 Gilead Sciences 190.71 Bn 164.90 Bn 6.22 Bn
9 Pfizer 170.03 Bn 116.68 Bn 10.94 Bn
10 Aldeyra Therapeutics 43.06 Mn -212.37 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -559,761.00
Dec 31, 2023 -1.58 Mn
Sep 30, 2023 -532,951.00
Sep 30, 2019 278,470.00
Jun 30, 2019 -1,656.00
Mar 31, 2019 -400,000.00
Dec 31, 2017 27,269.00
Sep 30, 2017 60,719.00
API Access

Aldeyra Therapeutics Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=ALDX&period=max&api_key=YOUR_API_KEY